Literature DB >> 15200435

Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension.

Daniel I Feig1, Takahiko Nakagawa, S Ananth Karumanchi, William J Oliver, Duk-Hee Kang, Jennifer Finch, Richard J Johnson.   

Abstract

BACKGROUND: Essential hypertension affects more than 25% of the world's population. Genetic, physiologic, and epidemiologic studies provide clues to its origins, but a clear understanding has been elusive. Recent experimental and clinical studies have implicated uric acid in the onset of essential hypertension.
METHODS: In a retrospective chart review, we identified 95 children with confirmed, new onset hypertension, and evaluated the cause of hypertension and parental history of hypertension, birth weight, and serum uric acid. In an open-label, cross-over trial we treated 5 children with confirmed essential hypertension with allopurinol as single treatment agent, and screened for change in blood pressure by casual and ambulatory methods. In tissue culture experiments, we evaluated the effect of uric acid on glomerular endothelial cell function.
RESULTS: Elevation of serum uric acid is related to the onset of essential hypertension in children, reduced birth weight, and endothelial dysfunction. Normalization of uric acid appears to ameliorate new onset essential hypertension.
CONCLUSION: These findings, combined with animal model data, support the hypothesis that uric acid has a key role in the pathogenesis of early onset essential hypertension, and may unify some of the disparate theories of the origins of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15200435     DOI: 10.1111/j.1523-1755.2004.00729.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  60 in total

1.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

Review 2.  Does dietary salt increase the risk for progression of kidney disease?

Authors:  Shiraz I Mishra; Charlotte Jones-Burton; Jeffrey C Fink; Jeanine Brown; George L Bakris; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 3.  The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease.

Authors:  Richard J Johnson; Eric A Gaucher; Yuri Y Sautin; George N Henderson; Alex J Angerhofer; Steven A Benner
Journal:  Med Hypotheses       Date:  2008-03-10       Impact factor: 1.538

Review 4.  Pathogenesis of essential hypertension: historical paradigms and modern insights.

Authors:  Richard J Johnson; Dan I Feig; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Bernardo Rodriguez-Iturbe
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

Review 5.  Update on gout: pathophysiology and potential treatments.

Authors:  Aryeh M Abeles; Jean Y Park; Michael H Pillinger; Bruce N Cronstein
Journal:  Curr Pain Headache Rep       Date:  2007-12

6.  Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress.

Authors:  Christine Gersch; Sergiu P Palii; Witcha Imaram; Kyung Mee Kim; S Ananth Karumanchi; Alexander Angerhofer; Richard J Johnson; George N Henderson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-02       Impact factor: 1.381

Review 7.  The long-term renal and cardiovascular consequences of prematurity.

Authors:  Carolyn L Abitbol; Maria M Rodriguez
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

Review 8.  Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?

Authors:  Mark S Segal; Elizabeth Gollub; Richard J Johnson
Journal:  Eur J Nutr       Date:  2007-09-01       Impact factor: 5.614

Review 9.  Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.

Authors:  J L Pirkle; B I Freedman
Journal:  Minerva Urol Nefrol       Date:  2013-03       Impact factor: 3.720

10.  The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease.

Authors:  Peter Higgins; Jesse Dawson; Matthew Walters
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.